Skip to results
Modify your search
NARROW
1-9 of 9
Authors: Francesco Franchi
Journal Article
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis Free
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 6, September 2024, Pages 526–536, https://doi.org/10.1093/ehjcvp/pvae036
Published: 16 May 2024
Journal Article
1156 CANGRELOR IN PATIENTS WITH CORONARY ARTERY DISEASE PRE-TREATED WITH TICAGRELOR: THE SWITCHING ANTIPLATELET (SWAP)-5 STUDY Free
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.769, https://doi.org/10.1093/eurheartjsupp/suac121.769
Published: 15 December 2022
Journal Article
1157 WITCHING FROM DUAL ANTIPLATELET THERAPY WITH ASPIRIN PLUS A P2Y12 INHIBITOR TO DUAL PATHWAY INHIBITION WITH ASPIRIN PLUS VASCULAR-DOSE RIVAROXABAN: THE SWITCHING ANTI-PLATELET AND ANTI-COAGULANT THERAPY (SWAP-AC) STUDY Free
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.768, https://doi.org/10.1093/eurheartjsupp/suac121.768
Published: 15 December 2022
Journal Article
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy Free
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 7, November 2022, Pages 728–737, https://doi.org/10.1093/ehjcvp/pvac022
Published: 30 March 2022
Journal Article
EDITOR'S CHOICE
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials Free
European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 959–967, https://doi.org/10.1093/eurheartj/ehab836
Published: 16 December 2021
Journal Article
10 Pharmacodynamic profiles of aspirin versus dual-pathway inhibition with either aspirin or clopidogrel among patients with stable atherosclerotic disease Free
European Heart Journal Supplements, Volume 23, Issue Supplement_G, December 2021, suab129.004, https://doi.org/10.1093/eurheartj/suab129.004
Published: 08 December 2021
Journal Article
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials Free
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 7, November 2022, Pages 677–686, https://doi.org/10.1093/ehjcvp/pvab070
Published: 14 September 2021
Journal Article
Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease Free
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 5, September 2022, Pages 452–461, https://doi.org/10.1093/ehjcvp/pvab042
Published: 11 June 2021
Journal Article
EDITOR'S CHOICE
A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study Get access
European Heart Journal, Volume 37, Issue 35, 14 September 2016, Pages 2722–2730, https://doi.org/10.1093/eurheartj/ehv744
Published: 03 February 2016
